• BIA Blog

Guest Blog |Is now the time for genomic medicine?

The Covid-19 pandemic has permanently altered the world; for the life sciences sector it has opened the doors of opportunity very wide. Over the last year, the sector has seen record levels of attention, investment and support from regulators. The world is invested in the innovation that our sector is able to bring to revolutionise healthcare – so is now the time for genomic medicine to shine?

CEO Update | 21 June 2021

Following the Prime Minister’s announcement last Monday that COVID-19 restrictions were to be extended by a further four weeks in England, we have taken the difficult decision to postpone the BIA’s Garden Party. We hope to hold the event in person in September and we will share details once the new arrangements with the venue have been confirmed.

CEO update | 14 June 2021

I was delighted to read on Friday night that many colleagues and BIA members were rightly recognised in the Queen’s Birthday Honours List 2021. The headlines were dominated by Kate Bingham, former Chair of the UK’s Vaccine Taskforce (VTF) and Professor Sarah Gilbert of Oxford University who both became Dames.

CEO Update | 07 June 2021

Following a major campaign by the BIA to secure fresh funding for the Biomedical Catalyst, details of the new competition have gone live today on the Innovate UK website which can be found here.

CEO Update | 24 May 2021

Following a major campaign by the BIA to secure fresh funding for the Biomedical Catalyst, which many of you have supported, great news last week as the Government announced a £30m refill for a new round this year. Read our press release here and you can read more about the BIA’s decade-long campaign on the BMC, here.

Guest Blog | Government commits to looking deeper at how the IP system can support AI-driven innovation

On 23 March 2021, the UK Government published its response to its call for views on artificial intelligence and intellectual property. This was an important consultation looking at a range of issues, but most significantly for the life sciences sector, it asked if inventions derived from artificial intelligence (AI) machines should be afforded the same protections as human inventions. The BIA was amongst those who took part in the consultation. 

CEO Update | 17 May 2021

As the COVID-19 pandemic continues worldwide, I chaired an emergency Board meeting of the International Council of Biotech Associations (ICBA) on what more our sector can do to help the global vaccination effort.

BIA reaction to the Queen's Speech

The Government has used the Queen’s Speech to highlight its ambition to lead the world in life sciences as part of its plans for economic recovery from the COVID-19 pandemic on the back of the successful vaccination programme. Improving health, creating jobs and levelling up were other key themes set out as the foundations for the Government’s policy agenda.  

CEO Update | 10 May 2021

Jabbed! a TV documentary telling the inside story of the UK Vaccines Taskforce is on Channel 4 this evening at 10pm. Tune in to see interviews with familiar faces including Kate Bingham and Ian McCubbin. I hope the documentary puts front and centre the early work done by the BIA COVID-19 Vaccine Manufacturing Taskforce as part of the UK’s great vaccine story.

Guest Blog | Will Covid-19 herald a new era for clinical trial research across Europe?

Clinical trials are an essential part of getting new treatments from lab to patient but during the COVID-19 pandemic, trials for treatments outside of COVID-19 had been heavily disrupted. However, in light of all this immediate disruption there have been claims that the swift action taken to produce a vaccine and the adoption of technology could set a positive precedent for the future of clinical trial research.